CMS denies reimbursement for CT colonography screening
The Centers for Medicare and Medicaid Services has proposed that payment for CT colonography be declined, saying there is not enough evidence to support it as a colorectal cancer screening tool.
The Centers for Medicare and Medicaid Services has proposed that payment for CT colonography be declined, saying there is not enough evidence to support it as a colorectal cancer screening tool.
In a Proposed Decision Memorandum issued Feb. 11, CMS suggests that existing scientific evidence is inadequate to conclude that CTC improves net health benefits for asymptomatic, average risk Medicare beneficiaries. CMS thus decided that CTC for colorectal cancer screening should remain uncovered.
"While it is a promising technology, many questions on the use of CT colonography need to be answered with well-designed clinical studies that focus on health outcomes for the Medicare population. Until the evidence is sufficient, CMS strongly encourages physicians and beneficiaries to participate in colorectal cancer screening by selecting one of the several CRC screening tests that are currently covered under Medicare," CMS said in its memo.
CMS requested public feedback on the proposed determination and announced it will issue a final decision after considering comments. In its statement, however, CMS cautioned that even if it finds that CTC is clinically effective, additional information and public comments would be needed to determine the test cost effectiveness.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
